Skip to content
RoyalWorks

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Deal Because of Information Concerns

Health funding illustration
The proposed American financial assistance was intended for programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's insistence on confidential information.

The decision was revealed after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "lopsided".

A government representative has since stated that the US was requesting genetic material for scientific study and commercial purposes but was not willing to share the resulting advantages from any future vaccines.

"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for more talks to secure a deal agreeable to both sides so the country's critical HIV programme can be sustained.

Wider Context

This rejection comes after a similar case in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the safety of Kenyans' medical information.

Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to boost transparency and accountability.

As per statements, 16 nations in Africa have so far agreed to similar agreements, constituting over $18.3bn of fresh investment.

Details of the Rejected Deal

This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont said.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our nation would provide the basic resources for medical research with no assurance that the end products would be available to our population if a future disease outbreak arise."

National Interest and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks already set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.

"This framework is intended to ensure that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We are open to further dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of both nations."

Medical Community Response

Medical experts expressed it understood the government's concerns, but recommended that negotiations should continue given that much of the country's HIV programmes were funded by external financing.

"In cases where technical issues arise, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.

The situation emphasises the continuing tensions between receiving much-needed foreign assistance and protecting local interests in an ever more interconnected world.

MM
Written by

Melissa Moore

A digital strategist with over a decade of experience in web development and marketing, specializing in creating impactful online presences.

RoyalWorks

Type to search articles.